UK To Test Third Vaccine Dose In Immunocompromised People
Data From OCTAVE Study Show Low Response In 40% Of Patients After Two Doses
Initial results of the OCTAVE DUO study are expected later this year and will feed into the UK’s deployment of COVID-19 vaccines in people with weakened immune systems.
